NETRIS PHARMA
Patent Applications and Registrations
Patent applications and USPTO patent grants for NETRIS PHARMA.The latest application filed is for "novel anti-netrin-1 antibody".
- NETRIS PHARMA - LYON FR
- NETRIS PHARMA - Lyons N/A FR
Trademarks
| Patent | Date |
|---|---|
| Novel Anti-netrin-1 Antibody App 20200079842 - DELCROS; Jean-Guy ; et al. | 2020-03-12 |
| Anti-netrin-1 antibody Grant 10,494,427 - Delcros , et al. De | 2019-12-03 |
| Combined Treatment With Netrin-1 Interfering Drug And Immune Checkpoint Inhibitors Drugs App 20190315852 - DUCAROUGE; Benjamin ; et al. | 2019-10-17 |
| Novel Anti-netrin-1 Antibody App 20180072800 - DELCROS; Jean-Guy ; et al. | 2018-03-15 |
| Combined treatment with netrin-1 interfering drug and chemotherapeutic drug Grant 9,895,439 - Mehlen , et al. February 20, 2 | 2018-02-20 |
| Combined Treatment with Netrin-1 Interfering Drug and Chemotherapeutic Drug App 20150246116 - Mehlen; Patrick ; et al. | 2015-09-03 |
| Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents App 20130149306 - Royet; Amelie ; et al. | 2013-06-13 |
| Method And Compositions To Induce Apoptosis Of Tumoral Cells Expressing Shh App 20130089548 - Mehlen; Patrick ; et al. | 2013-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 